A. Egwuenu

发表

An ST131 clade and a Phylogroup A clade bearing a novel Escherichia coli O-antigen cluster predominate among bloodstream E. coli isolates from southwest Nigeria hospitals

I. Okeke, D. Aanensen, C. Ihekweazu, 2021, medRxiv.

Clones and Clusters of Antimicrobial-Resistant Klebsiella From Southwestern Nigeria

I. Okeke, D. Aanensen, C. Ihekweazu, 2021, bioRxiv.

COVID-19 mortality rate and its associated factors during the first and second waves in Nigeria

E. Igumbor, C. Ihekweazu, C. King, 2022, PLOS global public health.

Tackling antimicrobial resistance across sub-Saharan Africa: current challenges and implications for the future

Z. Saleem, J. Mwita, A. Guantai, 2022, Expert opinion on drug safety.

Establishing a national reference laboratory for antimicrobial resistance using a whole-genome sequencing framework: Nigeria's experience.

I. Okeke, D. Aanensen, M. Kekre, 2022, Microbiology.

Genomic characterization of invasive typhoidal and non-typhoidal Salmonella in southwestern Nigeria

I. Okeke, D. Aanensen, M. Kekre, 2022, medRxiv.

Baseline study for improving diagnostic stewardship at secondary health care facilities in Nigeria

T. Eckmanns, A. V. von Laer, C. Ihekweazu, 2021, Antimicrobial Resistance and Infection Control.

Molecular characterization of multi drug resistant Escherichia coli isolates at a tertiary hospital in Abuja, Nigeria

S. Thakur, S. Obaro, L. Harden, 2022, Scientific Reports.

Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries

Z. Saleem, J. Mwita, B. Godman, 2021, Life.

Descriptive epidemiology of coronavirus disease 2019 in Nigeria, 27 February–6 June 2020

E. Igumbor, C. Ihekweazu, D. Olaleye, 2020, Epidemiology and Infection.

An ST131 clade and a phylogroup A clade bearing an O101-like O-antigen cluster predominate among bloodstream Escherichia coli isolates from South-West Nigeria hospitals

I. Okeke, D. Aanensen, C. Ihekweazu, 2022, Microbial genomics.

Antimicrobial use and resistance in Nigeria: situation analysis and recommendations, 2017

I. Okeke, C. Ihekweazu, A. Olayinka, 2018 .

Antimicrobial use among hospitalized patients: A multi-center, point prevalence survey across public healthcare facilities, Osun State, Nigeria.

A. Aboderin, A. T. Adeyemo, A. Egwuenu, 2021, Germs.

Global Antimicrobial Resistance and Use Surveillance System on the African continent: Early implementation 2017–2019

O. Perovic, Grace Najjuka, Y. Ahmed, 2022, African journal of laboratory medicine.

Multi-drug resistance and high mortality associated with community-acquired bloodstream infections in children in conflict-affected northwest Nigeria

H. Wertheim, C. Ariti, J. Hopman, 2021, Scientific Reports.

Implementing an emergency risk communication campaign in response to the COVID-19 pandemic in Nigeria: lessons learned

C. Ochu, O. Oyebanji, C. Anueyiagu, 2022, BMJ Global Health.

High Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii Isolates Recovered in Nigerian Hospitals in 2016 to 2020

I. Okeke, D. Aanensen, A. Dalsgaard, 2023, mSphere.

High genetic diversity and blaNDM-1 prevalence among Acinetobacter baumannii in Nigerian hospitals

I. Okeke, D. Aanensen, A. Dalsgaard, 2023, bioRxiv.

Complete Genome Sequence of Pseudomonas Phage Zikora

N. E. Nnadi, C. Okonkwo, G. Resch, 2021, Microbiology resource announcements.

Tetanus and Diphtheria Seroprotection among Children Younger Than 15 Years in Nigeria, 2018: Who Are the Unprotected Children?

F. Shuaib, Heather M. Scobie, C. Ihekweazu, 2023, Vaccines.

Operationalising One Health in Nigeria: Reflections From a High-Level Expert Panel Discussion Commemorating the 2020 World Antibiotics Awareness Week

D. Ogbolu, Olaniyi Ayobami, J. Kabir, 2021, Frontiers in Public Health.

Beyond drug treatment: a cross-sectional assessment of palliative care services for people living with HIV/AIDS at public health facilities, Abuja, Nigeria

Muhammad Shakir Balogun, K. Sabitu, W. S. Ajisegiri, 2021, The Pan African medical journal.